125.12CHF-0.97%Mkt Cap: 274.07B $P/E: 23.57Today
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap274.07B $
Enterprise Value321.78B $
Revenue (TTM)64.70B $
Gross Profit49.05B $
Net Income (TTM)15.96B $
Revenue/Share33.82 USD
Last Price125.12 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75.3K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)23.57
P/E (Forward)15.94
PEG3.58
EV/EBITDA12.21
EV/Revenue4.97
P/S4.19
P/B7.05
EPS (TTM)5.33
EPS (Forward)7.83
52W Range
96.0382% of range131.50
52W High131.50 CHF
52W Low96.03 CHF
Profitability
Gross Margin75.83%
Oper. Margin34.62%
EBITDA Margin40.74%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth0.80%
Earnings Growth-17.00%
Cash Flow & Leverage
Operating CF21.85B $
CapEx (TTM)4.45B $
FCF Margin20.99%
FCF Yield4.96%
Net Debt47.25B $
Net Debt/EBITDA1.79
Balance Sheet
Debt/Equity0.77
Current Ratio0.86
Quick Ratio0.55
Book Value/Sh17.70 CHF
Cash/Share4.008 CHF
Dividends
Fwd Div Rate3.700 CHF
Trail. Div Rate4.666 CHF
Div. Yield2.93%
5Y Avg Yield3.57%
Payout Ratio69.86%
Ex-Div DateMar 10, 2026
Pay DateMar 13, 2025
Splits
Last Split6:5
Split DateOct 4, 2023
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)123.17 CHF
Upside (mean)-1.6%
Target Range93.64 CHF – 139.63 CHF
CHF93.64-1.6% to meanCHF139.63
# Analysts21
Ownership
Shares Out.1.90B
Float1.86B
Insiders2.11%
Institutions45.89%
Technical
SMA 50124.76 (+0.3%)
SMA 200118.16 (+5.9%)
Beta0.49
S&P 52W Chg18.16%
Avg Vol (30d)2.14M
Avg Vol (10d)1.79M
Technical Indicators
RSI (14)52.9
MACD0.2983
MACD Signal0.4301
MACD Hist.-0.1318
BB Upper130.05 CHF
BB Middle126.25 CHF
BB Lower122.46 CHF
BB Width6.02%
ATR (14)2.553 CHF
Vol Ratio (20d)0.88x